BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11425670)

  • 21. [Proliferative vitreoretinopathy--pathogenesis and therapy].
    Iandiev I; Bringmann A; Wiedemann P
    Klin Monbl Augenheilkd; 2010 Mar; 227(3):168-74. PubMed ID: 20234978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vitrectomy with daunorubicin].
    Raczyńska K; Gebka A; Iwaszkiewicz-Bilikiewicz B; Ciechanowski C
    Klin Oczna; 2004; 106(3 Suppl):481-4. PubMed ID: 15636243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to predict proliferative vitreoretinopathy: a prospective study.
    Asaria RH; Kon CH; Bunce C; Charteris DG; Wong D; Luthert PJ; Khaw PT; Aylward GW
    Ophthalmology; 2001 Jul; 108(7):1184-6. PubMed ID: 11425672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Postoperative appearance of subretinal fibrosis in rhegmatogenous retinal detachment].
    Lezrek O; El Moize Z; Daoudi C; Ben Dali I; Tachfouti S; Lezrek M
    J Fr Ophtalmol; 2018 Feb; 41(2):190-191. PubMed ID: 29395596
    [No Abstract]   [Full Text] [Related]  

  • 25. SMOKING IS A RISK FACTOR FOR PROLIFERATIVE VITREORETINOPATHY AFTER TRAUMATIC RETINAL DETACHMENT.
    Eliott D; Stryjewski TP; Andreoli MT; Andreoli CM
    Retina; 2017 Jul; 37(7):1229-1235. PubMed ID: 27787448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed occurrence of subretinal silicone oil after retinal detachment surgery in an optic disc pit--a case report.
    Becht C; Senn P; Lange AP
    Klin Monbl Augenheilkd; 2009 Apr; 226(4):357-8. PubMed ID: 19384802
    [No Abstract]   [Full Text] [Related]  

  • 27. [Surgical outcomes of vitrectomy for retinal detachment due to macular hole with proliferative vitreoretinopathy].
    Tsuruoka M; Mitamura Y; Nakahara M; Ishida M; Tsukahara I; Kasai H; Yamamoto S; Takeuchi S
    Nippon Ganka Gakkai Zasshi; 1998 Sep; 102(9):583-6. PubMed ID: 9785855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary vitrectomy for rhegmatogenous retinal detachment without use of heavy liquids].
    Neuhann I; Bartz-Schmidt KU
    Klin Monbl Augenheilkd; 2013 Oct; 230(10):1025-8. PubMed ID: 23842871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Liquid perfluorocarbons in vitreo-retinal surgery].
    Benchekroun O; Lahbil D; Rachid R; Laaouissi N; Zaghloul K; Amraoui A
    J Fr Ophtalmol; 1998 Dec; 21(10):773-81. PubMed ID: 10052053
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravitreal low molecular weight heparin in PVR surgery.
    Kumar A; Nainiwal S; Sreenivas B
    Indian J Ophthalmol; 2003 Mar; 51(1):67-70. PubMed ID: 12701865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Surgical Technique for the Management of Retinal Detachment Associated With Severe Proliferative Vitreoretinopathy.
    Tabandeh H
    Retina; 2017 Jul; 37(7):1407-1410. PubMed ID: 28125442
    [No Abstract]   [Full Text] [Related]  

  • 32. Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy.
    Storey P; Alshareef R; Khuthaila M; London N; Leiby B; DeCroos C; Kaiser R;
    Retina; 2014 Oct; 34(10):1945-51. PubMed ID: 24999720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal Detachment and Proliferative Vitreoretinopathy.
    Kwon OW; Song JH; Roh MI
    Dev Ophthalmol; 2016; 55():154-62. PubMed ID: 26501375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retinal detachment with vitreous hemorrhage].
    Li C
    Yan Ke Xue Bao; 1995 Dec; 11(4):224-6. PubMed ID: 9275751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Posterior subcapsular cataract after vitrectomy].
    Bettich Z; Lezrek O; Lezrek M; Tachfouti S; Ouafae Cherkaoui L
    J Fr Ophtalmol; 2018 Nov; 41(9):896-897. PubMed ID: 30389180
    [No Abstract]   [Full Text] [Related]  

  • 36. CHOROIDAL THICKNESS CHANGES AFTER VITRECTOMY WITH SILICONE OIL TAMPONADE FOR PROLIFERATIVE VITREORETINOPATHY RETINAL DETACHMENT.
    Odrobina D; Gołębiewska J; Maroszyńska I
    Retina; 2017 Nov; 37(11):2124-2129. PubMed ID: 28033232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors, anatomical, and visual outcomes of injured eyes with proliferative vitreoretinopathy: eye injury vitrectomy study.
    Feng K; Hu Y; Wang C; Shen L; Pang X; Jiang Y; Nie H; Wang Z; Ma Z
    Retina; 2013 Sep; 33(8):1512-8. PubMed ID: 23538583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.
    Lai FH; Lo EC; Chan VC; Brelen M; Lo WL; Young AL
    Int Ophthalmol; 2016 Apr; 36(2):217-24. PubMed ID: 26260357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case of rubeosis in association with proliferative vitreoretinopathy (PVR).
    Bourke RD; Cooling RJ
    Retina; 1997; 17(3):262-4. PubMed ID: 9196943
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
    Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
    Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.